Intrinsiqq
Novartis AG Registered Shares logo

Novartis AG Registered Shares Financials

NOVN.XSWX

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$56,693$56,674$40,180$46,660$43,461$43,974
Cost of Revenue$14,319$13,699$9,965$12,472$11,582$11,735
Gross Profit$42,374$42,975$30,216$34,188$31,879$32,239
Total Operating Expenses$25,272$25,331$18,917$24,419$23,933$22,183
Operating Income$17,102$17,644$11,299$9,769$7,946$10,056
Non-Operating
Net Interest Expense-$1,390-$1,144-$782-$855-$800-$787
Income Tax Expense$2,775$2,385$1,321$551$1,128$1,625
Net Income
Net Income$12,747$13,967$9,275$14,854$6,955$24,018
Per Share Data
Revenue Per Share$29.62$29.23$25.63$20.45$18.14$17.84
EPS (Basic)$6.63$7.21$5.92$7.15$3.19$10.71
EPS (Diluted)$6.62$7.15$5.87$7.10$3.17$10.63
Shares Outstanding1.91B1.94B1.57B2.28B2.40B2.46B
Dividends Per Share$4.77$4.77$3.98$3.75$2.84$2.78

Novartis AG Registered Shares (NOVN.XSWX) financials: revenue, profit and margins

Novartis AG Registered Shares (NOVN.XSWX) generated about $56.7 billion in revenue and $12.7 billion in net income (a 22.5% net margin) over the trailing twelve months, growing at roughly 6.5% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Novartis AG Registered Shares's (NOVN.XSWX) revenue?+

Novartis AG Registered Shares generated about $56.7 billion in revenue over the trailing twelve months. Revenue has grown at roughly 6.5% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Novartis AG Registered Shares profitable?+

Yes, Novartis AG Registered Shares reported about $12.7 billion in net income over the trailing twelve months, a net profit margin of roughly 22.5%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Novartis AG Registered Shares's profit margins?+

Novartis AG Registered Shares runs a gross margin of about 74.7%, an operating margin of about 30.2%, a net margin of about 22.5%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Novartis AG Registered Shares growing?+

Novartis AG Registered Shares's revenue has compounded at roughly 6.5% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside NOVN.XSWX's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Drug Manufacturers - General · Pick stocks to compare with NOVN.XSWX

CompareIntrinsic value
RO.XSWXRoche Holding AG
CHF 402.60-0.84%54
SDZ.XSWXSandoz Group AG
CHF 80.82-0.65%34
ALCE.XSWXAlcon N 2.Linie
No recent price16
LONN.XSWXLonza Group AG
CHF 652.40-2.34%17
AZN.XLONAstraZeneca PLC
£134.12+0.81%56
0010V0.XKRXJPI Healthcare Co., Ltd.
₩6,250.00-2.50%58
BAYN.XETRBayer AG
€53.36-2.41%32
001360.XKRXSamsung Pharmaceutical Co., Ltd.
₩1,221.00-3.86%0

Held by ETFs

NOVN.XSWX is in 172 US ETFs. The largest of them, with NOVN.XSWX's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing NOVN.XSWX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.